Login | Register

Malaria vaccine protects children for up to 18 months

Results from a large-scale Phase III African trial of an experimental malaria vaccine by GlaxoSmithKline (GSK) shows that it continued to protect young children up to 18 months after vaccination. Malaria kills 660,000 people a year, mostly children living in sub-Saharan Africa...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *